Indication
Chronic bronchitis with bacterial exacerbation
Chronic bronchitis with bacterial exacerbation is an acute, clinically significant worsening of lower respiratory tract symptoms in individuals with preexisting chronic bronchitis, a condition characterized by long-term bronchial inflammation and hypersecretion. Read more about Chronic bronchitis with bacterial exacerbation
299 drugs 133 manufacturers
Drugs that treat it
Common Chronic bronchitis with bacterial exacerbation therapies.
AMPICILLIN TRIHYDRATE
AZITHROMYCIN
LEVOFLOXACIN
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
ZITHROMAX (azithromycin)
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
AZITHROMYCIN
AMPICILLIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic bronchitis with bacterial exacerbation is an acute, clinically significant worsening of lower respiratory tract symptoms in individuals with preexisting chronic bronchitis, a condition characterized by long-term bronchial inflammation and hypersecretion.
It primarily affects adults with underlying airway disease, most frequently in the context of chronic obstructive pulmonary disease (COPD) and chronic tobacco smoke or pollutant exposure.
Pathophysiologically, secondary or primary bacterial proliferation—commonly involving organisms such as *Haemophilus influenzae*, *Streptococcus pneumoniae*, or *Moraxella catarrhalis*—triggers intensified airway mucosal inflammation and impaired mucociliary clearance.
Clinically, this episode is defined by an acute increase in dyspnea, sputum volume, and sputum purulence beyond the patient's baseline day-to-day variation.
- nih.gov
Chronic bronchitis with bacterial exacerbation is an acute, clinically significant worsening of lower respiratory tract symptoms in individuals with preexisting chronic bronchitis, a condition characterized by long-term bronchial inflammation and hypersecretion It primarily affects adults with underlying airway disease, most frequently in the context of chronic obstructive pulmonary disease (COPD) and chronic tobacco smoke or pollutant exposure
- nih.gov
Chronic bronchitis with bacterial exacerbation is an acute, clinically significant worsening of lower respiratory tract symptoms in individuals with preexisting chronic bronchitis, a condition characterized by long-term bronchial inflammation and hypersecretion
- fda.gov
It primarily affects adults with underlying airway disease, most frequently in the context of chronic obstructive pulmonary disease (COPD) and chronic tobacco smoke or pollutant exposure
- nih.gov
Pathophysiologically, secondary or primary bacterial proliferation—commonly involving organisms such as *Haemophilus influenzae*, *Streptococcus pneumoniae*, or *Moraxella catarrhalis*—triggers intensified airway mucosal inflammation and impaired mucociliary clearance
- nih.gov
Pathophysiologically, secondary or primary bacterial proliferation—commonly involving organisms such as *Haemophilus influenzae*, *Streptococcus pneumoniae*, or *Moraxella catarrhalis*—triggers intensified airway mucosal inflammation and impaired mucociliary clearance
- nih.gov
Clinically, this episode is defined by an acute increase in dyspnea, sputum volume, and sputum purulence beyond the patient's baseline day-to-day variation
- nih.gov
Clinically, this episode is defined by an acute increase in dyspnea, sputum volume, and sputum purulence beyond the patient's baseline day-to-day variation
Personalize your experience
Follow Chronic bronchitis with bacterial exacerbation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.